BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 107.12% | 35.16% | 37.99% | 15.68% | -22.02% |
| Total Depreciation and Amortization | -100.00% | 531.58% | -66.07% | -51.30% | -37.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.04% | -263.73% | -64.35% | 103.76% | 812.34% |
| Change in Net Operating Assets | -143.08% | 364.98% | -73.91% | -13.28% | 410.64% |
| Cash from Operations | 92.04% | 33.46% | 19.90% | 30.02% | 13.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.27% | 679.25% | -- | -100.00% | -- |
| Repurchase of Common Stock | 92.86% | -16.67% | -100.00% | -20.00% | 82.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 36.20% | -- | 100.00% | 78.69% |
| Cash from Financing | -98.18% | -98.36% | 111,983.33% | 83.33% | 90.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.91% | -329.03% | 87.84% | 30.16% | 15.15% |